The aim of the present study was to evaluate the efficacy of tertiary and quaternary cytoreduction in recurrent ovarian cancer patients.
Fanfani, F., Fagotti, A., Ercoli, A., Gallotta, V., Chiantera, V., Restaino, S., et al. (2015). Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer?. ANTICANCER RESEARCH, 35(12), 6951-6956.
Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer?
Chiantera, Vito;
2015-01-01
Abstract
The aim of the present study was to evaluate the efficacy of tertiary and quaternary cytoreduction in recurrent ovarian cancer patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
11 6951.full.pdf
Solo gestori archvio
Dimensione
57.29 kB
Formato
Adobe PDF
|
57.29 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
